Fox Business - The Power to Prosper
Search Site


CUR

  • Last Update

  • Change

  • Volume / Avg.

  • Prev. Close

Today's Performance

52-Week Range

Neuralstem, Inc.

Neuralstem, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD.